The Role of Artificial Intelligence in Tackling COVID-19

References

• World Health Organization . Coronavirus disease 2019 (COVID-19): situation report. 156 (2020). www.who.int/docs/default-source/coronaviruse/situation-reports/20200624-covid-19-sitrep-156.pdf?sfvrsn=af42e480_2
   Google Scholar
• Cai H . Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir. Med., 8(4), e20 (2020).
   PubMed Web of Science ®Google Scholar
• Guan W , NiZ, HuYet al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 382(18), 1708–1720 (2020).
   PubMed Web of Science ®Google Scholar
• Ruan S . Likelihood of survival of coronavirus disease 2019. Lancet Infect. Dis., 20(6), 630–631 (2020).
   PubMed Web of Science ®Google Scholar
• Verity R , OkellLC, DorigattiIet al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect. Dis., 20(6), 669–677 (2020).
   PubMed Web of Science ®Google Scholar
• Yu N , LiW, KangQet al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect. Dis., 20(5), 559–564 (2020).
   PubMed Web of Science ®Google Scholar
• Kelvin AA , HalperinS. COVID-19 in children: the link in the transmission chain. Lancet Infect. Dis., 20(6), 633–634 (2020).
   PubMed Web of Science ®Google Scholar
• Kim J-M , ChungY-S, JoHJet al. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong. Public Health Res. Perspect., 11(1), 3–7 (2020).
   PubMedGoogle Scholar
• Walls AC , ParkYJ, TortoriciMA, WallA, McGuireAT, VeeslerD. Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 18(2), 281–292 (2020).
   Google Scholar
• Wang Q , QiuY, LiJY, ZhouZJ, LiaoCH, GeXY. A unique protease cleavage site predicted in the spike protein of the novel pneumonia coronavirus (2019-nCoV) potentially related to viral transmissibility. Virol. Sin., 20, 1–3 (2020).
   Google Scholar
• Lu R , ZhaoX, LiJet al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224), 565–574 (2020).
   PubMed Web of Science ®Google Scholar
• Khailany RA , SafdarM, OzaslanM. Genomic characterization of a novel SARS-CoV-2. Gene Rep., 100682, 1–6 (2020).
   Google Scholar
• Mousavizadeh L , GhasemiS. Genotype and phenotype of COVID-19: their roles in pathogenesis. J. Microbiol. Immunol. Infect. doi:10.1016/j.jmii.2020.03.022 (2020) ( Epub ahead of print).
   PubMedGoogle Scholar
• Tang B , BragazziNL, LiQ, TangS, XiaoY, WuJ. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect. Dis. Model., 5, 248–255 (2020).
   PubMedGoogle Scholar
• Cai J , SunW, HuangJet al. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg. Infect. Dis., 26(6), 1343–1345 (2020).
   PubMed Web of Science ®Google Scholar
• van Doremalen N , BushmakerT, MorrisDHet al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med., 382(16), 1564–1567 (2020).
   PubMed Web of Science ®Google Scholar
• Chen Y , ChenL, DengQet al. The presence of SARS-CoV-2 RNA in feces of COVID-19 patients. J. Med. Virol., 92(7), 833–840 (2020).
   PubMed Web of Science ®Google Scholar
• Hindson J . COVID-19: faecal-oral transmission?Nat. Rev. Gastro. Hepat., 17(5), 259–259 (2020).
   PubMed Web of Science ®Google Scholar
• Huang CT , LinHH, RuanSYet al. Efficacy and adverse events of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome: a meta-analysis. Crit. Care, 18(3), R102 (2014).
   PubMed Web of Science ®Google Scholar
• Bénézit F , TurnierPL, DeclerckCet al. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect. Dis., 20(9), 1014–1015 (2020).
   PubMed Web of Science ®Google Scholar
• Winter AK , HegdeST. The important role of serology for COVID-19 control. Lancet Infect. Dis., 20(7), 758–759 (2020).
   PubMed Web of Science ®Google Scholar
• Metsky HC , FreijeCA, Kosoko-ThoroddsenTS, SabetiPC, MyhrvoldC. CRISPR-based COVID-19 surveillance using a genomically-comprehensive machine learning approach. bioRxiv doi:10.1101/2020.02.26.967026 (2020). https://doi.org/10.1101/2020.02.26.967026v2.full.pdf+html
   Google Scholar
• Callaway E . The race for coronavirus vaccines: a graphical guide. Nature, 580(7805), 576 (2020).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Draft landscape of COVID-19 candidate vaccines. www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
   Google Scholar
• Wang Y , ZhangD, DuGet al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 395(10236), 1569–1578 (2020).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov . COVID-19 | Recruiting Studies.https://clinicaltrials.gov/ct2/results?term=COVID-19&Search=Apply&recrs=a&age_v=&gndr=&type=&rslt=
   Google Scholar
• Santosh KC . AI-driven tools for coronavirus outbreak: need of active learning and cross-population train/test models on multitudinal/multimodal data. J. Med. Syst., 44(5), 1–5 (2020).
   Web of Science ®Google Scholar
• Maghdid HS , GhafoorKZ, SadiqAS, CurranK, RabieK. A novel AI-enabled framework to diagnose coronavirus covid 19 using smartphone embedded sensors: design study. arXiv Preprint arXiv:2003.07434, 1–7 (2020). https://arxiv.org/abs/2003.07434
   Google Scholar
• Imran A , PosokhovaI, QureshiHNet al. AI4COVID-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app. Inform. Med. Unlocked, 100378, 1–31 (2020).
   Google Scholar
• Rahmatizadeh S , Valizadeh-HaghiS, DabbaghA. The role of artificial intelligence in management of critical COVID-19 patients. J. Cell. Mol. Anes., 5(1), 16–22 (2020).
   Google Scholar
• Sethy PK , BeheraSK. Detection of coronavirus disease (covid-19) based on deep features. Preprints doi:10.20944/preprints202003.0300.v1 (2020).
   Google Scholar
• Gozes O , Frid-AdarM, SagieNet al. Coronavirus detection and analysis on chest ct with deep learning. arXiv Preprint arXiv:2004.02640 (2020).
   Google Scholar
• Xu Z , ShiL, WangYet al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med., 8(4), 420–422 (2020).
   PubMed Web of Science ®Google Scholar
• Li L , QinL, XuZet al. Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT. Radiology, 200905, 1–16 (2020).
   Google Scholar
• Singh D , KumarV, VaishaliMK. Classification of COVID-19 patients from chest CT images using multi-objective differential evolution-based convolutional neural networks. Eur. J. Clin. Microbiol. Infect. Dis., 39, 1379–1389 (2020).
   PubMed Web of Science ®Google Scholar
• Farooq M , HafeezA. COVID-ResNet: a deep learning framework for screening of COVID-19 from radiographs. arXiv arXiv:2003.14395, 1–5 (2020).
   Google Scholar
• Alom MZ , RahmanMMS, NasrinMS, TahaTM, AsariVK. COVID_MTNet: COVID-19 detection with multi-task deep learning approaches. Preprints1–11 (2020).
   Google Scholar
• Soares F . A novel specific artificial intelligence-based method to identify COVID-19 cases using simple blood exams. MedRxiv doi:10.1101/2020.04.10.20061036 (2020).
   PubMedGoogle Scholar
• Rasheed J , JamilA, HameedAAet al. A survey on artificial intelligence approaches in supporting frontline workers and decision makers for COVID-19 pandemic. Chaos, Solitons & Fractals doi:10.1016/j.chaos.2020.110337 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Wu J , ZhangP, ZhangLet al. Rapid and accurate identification of COVID-19 infection through machine learning based on clinical available blood test results. MedRxiv doi:10.1101/2020.04.02.20051136 (2020).
   Google Scholar
• Iwendi C , BashirAK, PeshkarAet al. COVID-19 Patient health prediction using boosted random forest algorithm. Front. Public Health, 8, 357 (2020).
   PubMed Web of Science ®Google Scholar
• Miner AS , LaranjoL, KocaballiAB. Chatbots in the fight against the COVID-19 pandemic. NPJ Digit. Med., 3(1), 1–4 (2020).
   PubMed Web of Science ®Google Scholar
• Battineni G , ChintalapudiN, AmentaF. AI Chatbot design during an epidemic like the novel coronavirus. Healthcare, 8(2), 154 (2020).
   Web of Science ®Google Scholar
• Zini-The Healthcare AI . Coronavirus outbreak in India. https://zini.ai/corona
   Google Scholar
• Yan L , ZhangHT, XiaoYet al. Prediction of criticality in patients with severe Covid-19 infection using three clinical features: a machine learning-based prognostic model with clinical data in Wuhan. MedRxiv doi:10.1101/2020.02.27.20028027 (2020).
   Google Scholar
• Jiang X , CoffeeM, BariAet al. Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. Comput. Mat. Continua, 11(63), 537–541 (2020).
   Google Scholar
• Yang GZ , NelsonBJ, MurphyRRet al. Combating COVID-19 - the role of robotics in managing public health and infectious diseases. Sci. Robot., 5(40), 5589 (2020).
   Web of Science ®Google Scholar
• Zeng Z , ChenPJ, LewAA. From high-touch to high-tech: COVID-19 drives robotics adoption. Tourism Geographies, 22(3), 1–11 (2020).
   Web of Science ®Google Scholar
• Senior AW , EvansR, JumperJet al. Improved protein structure prediction usingpotentials from deep learning. Nature, 577(7792), 706–710 (2020).
   PubMed Web of Science ®Google Scholar
• Pfab J , PhanNM, SiD. DeepTracer: fast cryo-EM protein structure modeling and special studies on CoV-related complexes. bioRxiv doi:10.1101/2020.07.21.214064 (2020).
   Google Scholar
• Randhawa GS , SoltysiakMP, ElRoz Het al. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. PLoS ONE, 15(4), e0232391 (2020).
   PubMed Web of Science ®Google Scholar
• Favalli EG , BiggioggeroM, MaioliG, CaporaliR. Baricitinib for COVID-19: a suitable treatment?Lancet Infect. Dis., 20(9), 1012–1013 (2020).
   PubMed Web of Science ®Google Scholar
• Zhou Y , HouY, ShenJet al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov., 6(14), 1–18 (2020).
   PubMedGoogle Scholar
• Stebbing J , PhelanA, GriffinIet al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect. Dis., 20(4), 400–402 (2020).
   PubMed Web of Science ®Google Scholar
• Abdulla A , WangB, QianFet al. Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention. Adv. Ther., 3(7), 2000034 (2020).
   Google Scholar
• Redka DS , MacKinnonSS, LandonM, WindemuthA, KurjiN, ShahaniV. PolypharmDB, a deep learning-based resource, quickly identifies repurposed drug candidates for COVID-19. ChemRxiv doi:10.26434/chemrxiv.12071271.v1 (2020).
   Google Scholar
• Mahapatra S , NathP, ChatterjeeMet al. Repurposing therapeutics for COVID-19: rapid prediction of commercially available drugs through machine learning and docking. MedRxiv doi:10.1101/2020.04.05.20054254 (2020).
   Google Scholar
• Hu F , JiangJ, YinP. Prediction of potential commercially inhibitors against SARS-CoV-2 by multi-task deep model. arXiv preprint arXiv:2003.00728 (2020).
   Google Scholar
• Muratov E , ZakharovA. Viribus unitis: drug combinations as a treatment against COVID-19. ChemRxiv doi:10.26434/chemrxiv.12143355.v1 (2020).
   Google Scholar
• Moskal M , BekerW, RoszakRet al. Suggestions for second-pass anti-COVID-19 drugs based on the artificial intelligence measures of molecular similarity, shape and pharmacophore distribution. ChemRxiv doi:10.26434/chemrxiv.12084690.v2 (2020).
   Google Scholar
• Ong E , WongMU, HuffmanA, HeY. COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Front. Immunol., 11, 1581 (2020).
   PubMed Web of Science ®Google Scholar
• Rashid MT , WangD. CovidSens: a vision on reliable social sensing for COVID-19. Artif. Intell. Rev. doi:10.1007/s10462-020-09852-3 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Hung M , LaurenE, HonESet al. Social network analysis of COVID-19 Sentiments: application of artificial intelligence. J. Med. Internet Res., 22(8), e22590 (2020).
   PubMed Web of Science ®Google Scholar
• Khan R , ShrivastavaP, KapoorA, TiwariA, MittalA. Social media analysis with AI: sentiment analysis techniques for the analysis of twitter covid-19 data. J. Critical Rev., 7(9), 2761–2774 (2020).
   Google Scholar
• Samuel J , AliGG, RahmanM, EsawiE, SamuelY. Covid-19 public sentiment insights and machine learning for tweets classification. Information, 11(6), 314 (2020).
   Google Scholar
• Wang Z , LiL, YanJ, YaoY. Evaluating the Traditional Chinese Medicine (TCM) officially recommended in China for COVID-19 using ontology-based side-effect prediction framework (OSPF) and deep learning. Preprints doi:10.20944/preprints202002.0230.v1 (2020).
   Google Scholar
• Banerjee AK , AroraN. Coronavirus disease (COVID-19) pandemic: a race against time. Curr. Top. Med. Chem., 20(16), 1434–1437 (2020).
   PubMed Web of Science ®Google Scholar
• Zhavoronkov A , AladinskiyV, ZhebrakAet al. Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. ChemRxiv doi:10.26434/chemrxiv.11829102.v1, 1–20 (2020).
   Google Scholar